H.R. 9102 · House bill · 119th Congress
BINSA Act Introduced Jun 2, 2026 In committee Jun 2, 2026 Financial Services Passed the House (not yet) Passed the Senate (not yet) Law (not yet) What it would change (1) About this text
1 section of the Code · 4 changes asked for
Text: introduced in House Introduced The text as a member of Congress first filed it. Most bills never get further than this. , Jun 2, 2026 (the only version so far)
Official text on Congress.gov
Written by AIWhat this bill would change in the Code
This change would add biotechnology to the outbound-investment rules in the Defense Production Act definitions. It would be a new item in both the "prohibited technology" list and the "notifiable technology" list, covering research, development, manufacturing or commercialization of drugs, biological products, and therapeutic compounds (including drug discovery platforms, clinical research capabilities, biologics manufacturing, and related intellectual property). It would also add to the list of "covered national security transactions" a U.S. person's licensing of a prohibited technology from a covered foreign person.
This is the note on the one section the bill would change. It covers only changes to the Code. No person has checked it, and it can be wrong. The changes themselves are what the bill would do. About these notes
Sections are cited like “7 U.S.C. § 2012”: title Title One of the 54 subject areas the Code is divided into, such as Title 7 (Agriculture) or Title 26 (taxes). A title is split into chapters. 7 of the United States Code U.S.C. (United States Code) The United States Code: the federal laws in force, arranged by subject. "4 U.S.C. § 8" means title 4, section 8. , section Section (§) The basic unit of the Code, marked §. Each section has a number within its title and is cited like "7 U.S.C. § 2012". 2012.
50 U.S.C. Chapter 55 · Defense Production 1 section